T: (858) 822-0447
As Director of the Small Molecule Discovery Program, I lead a highly collaborative, systematic effort to use chemical biology to translate the cutting-edge research of Ludwig scientists into new cancer medicines.
Before joining Ludwig in 2009, I was Director of Biology at Kalypsys, where I supervised teams that helped advance multiple projects in metabolic diseases, pain/inflammation, ophthalmologic disorders, and oncology to the clinical stage. Before that I was head of the Orphan Nuclear Receptor Program at Tularik. I received my PhD in biochemistry and biophysics from the University of California, San Francisco.